Fukuda Denshi Finetech Sendai Co., Ltd.
2 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (2)
Devices registered here (3)
- System, Imaging, Pulsed Doppler, UltrasonicProduct code IYN (opens in a new tab) · Class II · Radiology · 21 CFR 892.1550
- Transducer, Ultrasonic, DiagnosticProduct code ITX (opens in a new tab) · Class II · Radiology · 21 CFR 892.1570
- System, Imaging, Pulsed Echo, UltrasonicProduct code IYO (opens in a new tab) · Class II · Radiology · 21 CFR 892.1560
Recalls & enforcement
- Class IICompleted2017-10-16For the Fukuda Denshi patient monitor model DS-8100, in less than 0.003% (17) of the 6227 devices sold worldwide, a Short-term Battery Error message has appeared and has been traced back to a bad (damaged) Lithium-Ion capacitor (Short-term battery backup).
- Class IITerminated2015-12-21A possible malfunction where a Short-term Battery Error message has appeared and has been traced back to a bad (damaged) Lithium-Ion capacitor (Short-term Backup battery).
Related
- All facilities operated by Fukuda Denshi Co., Ltd.
- FUKUDA DENSHI USA, INC. (WA)
- FUKUDA DENSHI CO., LTD. (JP)
- FUKUDA DENSHI CO., LTD. (JP)
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Fukuda Denshi Finetech Sendai Co., Ltd. (FEI 3010663777) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3010663777-fukuda-denshi-finetech-sendai-co-ltd/
Alerts for Fukuda Denshi Finetech Sendai Co., Ltd.
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.